Company Filing History:
Years Active: 1982
Title: Siegfried Silz: Innovator in Liver Growth Enhancement
Introduction
Siegfried Silz is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medical science, particularly in the area of liver growth enhancement. His innovative work has led to the development of a unique drug that has the potential to impact liver regeneration.
Latest Patents
Siegfried Silz holds a patent for a drug designed to enhance liver growth and the method of preparing it. The patent describes a factor that increases the number of liver cells through enhanced cell division activity. This factor is obtained by homogenizing the remaining livers of partially hepatectomized animals, followed by acidification to a pH of 5.5, heat treatment at 95 degrees Celsius, and centrifugation of the homogenate. The resulting supernatant contains a neuraminic-acid-free protein with a molecular weight of approximately 30,000 to 50,000 Daltons. Additionally, an extract containing this factor can also be derived from the blood plasma of hepatectomized animals when treated with neuraminidase. Furthermore, similar extracts can be obtained from the livers or plasma of non-hepatectomized fetal or very young animals.
Career Highlights
Siegfried Silz is associated with the Max Planck Society for the Advancement of Science, a prestigious research institution known for its contributions to various scientific fields. His work has been instrumental in advancing our understanding of liver biology and regenerative medicine.
Collaborations
Throughout his career, Siegfried has collaborated with esteemed colleagues such as Gerhard Ruhenstroth-Bauer and Michel Goldberg. These collaborations have further enriched his research and contributed to the development of innovative solutions in the medical field.
Conclusion
Siegfried Silz is a prominent figure in the realm of liver growth enhancement, with a patent that showcases his innovative approach to medical science. His contributions continue to pave the way for advancements in liver regeneration therapies.